HT
ANAB icon

Headlands Technologies’s AnaptysBio ANAB Stock Holding History

Headlands Technologies’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,558
Closed -$1.36M – 717
2026
Q1 		$1.36M Sell
24,558
-720
-3% -$38.7K 0.16% 147
2025
Q4 		$1.23M Buy
+25,278
New +$985K 0.1% 230
2024
Q4 		– Sell
-8,995
Closed -$301K – 1183
2024
Q3 		$301K Buy
8,995
+5,443
+153% +$186K 0.03% 427
2024
Q2 		$89K Buy
3,552
+2,900
+445% +$67.5K 0.01% 671
2024
Q1 		$14.7K Buy
652
+156
+31% +$3.69K ﹤0.01% 973
2023
Q4 		$10.6K Buy
+496
New +$8.55K ﹤0.01% 758

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Headlands Technologies's ANAB Position: Q2 2026 in Review

Headlands Technologies sold out of AnaptysBio (ANAB) in Q2 2026, closing a stake of 24,558 shares — an estimated $1.36M sold.

Headlands Technologies first reported a position in ANAB in Q4 2023 and held it in 6 quarters. The position peaked at $1.36M in Q1 2026. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Headlands Technologies reported no remaining AnaptysBio position as of Q2 2026 after selling out during the quarter.
  • Headlands Technologies sold 24,558 AnaptysBio shares in Q2 2026, an estimated $1.36M.
  • Headlands Technologies first reported a position in AnaptysBio in Q4 2023 and held it in 6 quarters.
  • Headlands Technologies's AnaptysBio position peaked at $1.36M in Q1 2026.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.